Clinical Trials Logo

Clinical Trial Summary

The FD/MAS Patient Registry is an IRB-approved research study that that invites the patients and families to help answer some of the biggest questions about FD/MAS by completing questionnaires about their lives with FD or MAS. Have you enrolled in the FD/MAS Patient Registry yet? Are you up-to-date on your surveys? Take a trip to www.fdmasregistry.org today to learn more about the project, enroll, complete your surveys, or make sure you aren't due to provide more info! The FD/MAS Patient Registry: Your story powers research.


Clinical Trial Description

The FD/MAS Patient Registry is an IRB approved research project that allows patients and families to share their experiences with fibrous dysplasia/McCune-Albright syndrome (FD/MAS) by completing a series of surveys. The surveys were created in collaboration with patients, parents, clinicians and researchers, so that the data can be used to answer some of the most important questions about FD/MAS, including: the way the disease develops over time (its "natural history"), the patient experience of the disease, and its impact on quality of life, how and when diagnoses are made, the scope of treatments in use, what surgical techniques work best, and for whom, what other medical interventions work best, and for whom, what social services and therapies are useful, the costs of care to patients and their families, issues that concern patients (such as the impact of pregnancy on FD, or children feeling different and facing stigma), and which research questions and support programs you think are important to fund. Participation is free and convenient for people with FD/MAS and their legal guardians. You can join today at www.fdmasregistry.org. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03231644
Study type Observational [Patient Registry]
Source Fibrous Dysplasia Foundation
Contact Carmel Shemmesh-Rafalowsky
Email PI.Registry@fibrousdysplasia.org
Status Recruiting
Phase
Start date October 31, 2016
Completion date October 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05419050 - Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia Phase 2
Completed NCT04931056 - A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.
Completed NCT05406544 - Df-Life : Quality of Life in Patients With Fibrous Dysplasia
Completed NCT04671719 - Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities
Recruiting NCT05966064 - DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) Phase 4
Withdrawn NCT03520153 - Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome